20096 ⎘
Medicinal preparations characterised by special physical form; Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
METHOD USING ROLLING MOLD TO PREPARE FREEZE-DRIED EXCIPIENT, AND PRODUCT THEREOF
#2102RECOMBINANT ELASTASE PROTEINS AND METHODS OF MANUFACTURING AND USE THEREOF
#2103Trans carotenoids, their synthesis, formulation and uses
#2104Peptide conjugated particles
#2105Spinal disc regenerative composition and method of manufacture and use
#2106Solid Pharmaceutical Composition Comprising Amorphous Sofosbuvir
#2107Freeze-dried preparation containing high-purity PTH and method for producing same
#2108Pharmaceutically active agent complexes, polymer complexes, and compositions and methods involving the same
#2109PROTEIN COMPOSITIONS AND USE THEREOF
#2110Process for preparing an attenuated tetravalent dengue vaccine
#2111Lyophilized cyclophosphamide composition and methods of preparation thereof
#2112Method for preparing liposome frozen powder capable of efficiently retaining its bilayer structure
#2113LIQUID COMPOSITION OF HUMAN ALBUMIN FOR THERAPEUTIC USE
#2114Compositions comprising bacterial strains
#2115Therapeutic compositions
#2116Donepezil derivative and use thereof
#2117Pharmaceutical composition comprising particles comprising a complex of a double-stranded polyribonucleotide and a polyalkyleneimine
#2118Pharmaceutical Formulation of an Anti-Guanylyl Cyclase C Antibody Conjugate Comprising Histidine or a Salt Thereof and Polysorbate 20
#2119NOROVIRUS VACCINE
#2120Microbiota restoration therapy (MRT) compositions and methods of manufacture
#2121Methods and therapeutic combinations for treating tumors
#2122Lyophilization of RNA
#2123Prokaryotic collagen therapeutics for postoperative adhesions
#2124Pharmaceutical composition containing camptothecin polymer derivative
#2125Subcutaneous therapeutic enzyme formulations, uses, and methods for generating thereof
#2126STABLE PHARMACEUTICAL COMPOSITION OF TNFR:FC FUSION PROTEIN
#2127ENZYME RESPONSIVE NANOCAPSULES FOR PROTEIN DELIVERY
#2128Antibody formulations and methods
#2129Carrier-binding agent compositions and methods of making and using the same
#2130Hydrophobic molecule-induced branched polymer aggregates and their use
#2131Subcutaneous anti-HER2 Antibody Formulations and Uses Thereof
#2132Heat stable liquid rotavirus vaccine
#2133bacterium for treatment of e.g. bacterial vaginosis
#2134Polyphenolic polymer to make water-insoluble molecules become water-soluble
#2135TIMED RELEASE OF SUBSTANCES TO TREAT OCULAR DISORDERS
#2136Compositions comprising bacterial strains
#2137Nanosuspension containing particles and extract of natural materials
#2138Pharmaceutical composition comprising an adenoviral vector
#2139Nucleic acid molecules encoding autoactivating type I pancreatic proelastase proteins
#2140METHODS OF TREATING ULCERATIVE COLITIS
#2141Stabilized liquid and lyophilized ADAMTS13 formulations
#2142Use of C-type natriuretic peptide variants to treat skeletal dysplasia
#2143Compositions comprising bacterial strains
#2144Compositions comprising bacterial strains
#2145Compositions comprising antibody-duocarmycin drug conjugates
#2146Methods of treatment using alpha-1-antitrypsin compositions
#2147Compositions comprising bacterial strains
#2148STARCH-BASED MICROPARTICLES FOR THE RELEASE OF AGENTS DISPOSED THEREIN
#2149Amniotic fluid formulation for treatment of joint pain or disorders
#2150Amniotic membrane preparations and purified compositions and therapy for scar reversal and inhibition
#2151Oral pharmaceutical dosage form for the delivery of a peptide and/or protein
#2152Cochleates made with soy phosphatidylserine
#2153Agent for preventing onset of idiopathic osteonecrosis of femoral head and/or suppressing progress of same
#2154Dry growth hormone composition transiently linked to a polymer carrier
#2155METHODS FOR PRODUCING ARIPIPRAZOLE SUSPENSION AND FREEZE-DRIED FORMULATION
#2156Bendamustine Solid Dispersions And Continuous Infusion
#2157ANTIBODY FORMULATION
#2158Liquid Protein Formulations Containing Thiamine
#2159Liquid protein formulations containing cimetidine
#2160Daptomycin formulations and uses thereof
#2161Antiviral methods and compositions comprising probiotic bacterial molecules
#2162Compositions for the Restoration of a Fecal Microbiota and Methods for Making and Using Them
#2163Methods of treating epithelioid cell tumors comprising administering a composition comprising nanoparticles comprising an mTOR inhibitor and an albumin
#2164Use of the FL-one hundred eighteen core chemical structure platform to generate FL-one hundred eighteen derivatives for treatment of human disease
#2165Ophthalmic drug delivery system containing phospholipid and cholesterol
#2166Anti-CD40 antibody formulation
#2167PROBIOTIC AND PREBIOTIC COMPOSITIONS, AND METHODS OF USE THEREOF FOR TREATMENT AND PREVENTION OF GRAFT VERSES HOST DISEASE
#2168Chitosan materials from carbonic acid solution
#2169PHARMACEUTICAL FORMULATION COMPRISING A SUBSTITUTED PHENYL - (1,3-DIHYDRO-ISOINDOL-2-YL) - METHANONE
#2170CEFTOLOZANE-TAZOBACTAM PHARMACEUTICAL COMPOSITIONS
#2171Malleable controlled release local anesthetic with hemostatic composition
#2172Cleavable lipids
#2173Particulate lyophilized platelet lysate compositions
#2174Theranostic bubble preparation (TB), and method for using same
#2175Nerve growth factor composition and powder injection
#2176Site-specific polyethylene glycolylated (pegylated) asparaginase, preparation method therefor and use thereof
#2177Pharmaceutical formulation containing tadalafil
#2178Method of lyophilizing liposomes
#2179Recombinant elastase proteins and methods of manufacturing and use thereof
#2180VEGF antagonist formulations suitable for intravitreal administration
#2181NUCLEIC ACID-CATIONIC POLYMER COMPOSITIONS AND METHODS OF MAKING AND USING THE SAME
#2182Liquid protein formulations containing thiamine pyrophosphate (TPP)
#2183Process for preparing a powder comprising a human coagulation factor protein and a lactic acid polymer
#2184Compositions and methods for preventing infections
#2185Compositions for fecal floral transplantation and methods for making and using them and device for delivering them
#2186MULTI-DRUG COMBINATIONS THAT ACT AS POTENT RADIOSENSITIZERS
#2187Stable Glucagon Peptide Formulations
#2188Nanoparticles for photodynamic therapy, X-ray induced photodynamic therapy, radiotherapy, radiodynamic therapy, chemotherapy, immunotherapy, and any combination thereof
#2189Stable and soluble formulations of receptor tyrosine kinase inhibitors, and methods of preparation thereof
#2190Duocarmycin ADCs showing improved in vivo antitumor activity
#2191Solid formulations of liquid biologically active agents
#2192COMPOSITIONS AND METHODS INVOLVING POLYMER, SOLVENT, AND HIGH VISCOSITY LIQUID CARRIER MATERIAL
#2193CELL-FREE METHODS OF DETECTING BIOACTIVE LIGANDS
#2194Stable formulations of 5,10-methylene-(6R)-tetrahydrofolic acid
#2195Compositions and methods for treating and preventing tissue injury and disease
#2196COMPOSITIONS AND METHOD FOR STABILIZING A PHARMACEUTICAL FORMULATION, AND METHODS OF MAKING AND USING THE SAME
#2197Compositions comprising bacterial strains
#2198Lyophilized mesna compositions
#2199DRUG-DELIVERING COMPOSITE STRUCTURES
#2200ANTIBODY DRUG CONJUGATES
#2201Treatment using dantrolene
#2202Stabilized pharmaceutical composition and method for preparing same
#2203Therapeutic microbiota for the treatment and/or prevention of food allergy
#2204Method of preparing albumin nanoparticle carrier wrapping taxane drug
#2205Use of von Willebrand factor
#2206NERVE GROWTH FACTOR COMPOSITION AND POWDER INJECTION
#2207DUAL CHAMBER DISPENSING DEVICE
#2208Ceftolozane antibiotic compositions
#2209METHODS AND PHARMACEUTICAL COMPOSITIONS FOR TREATING CELIAC DISEASE AND GLUTEN INTOLERANCE
#2210STABILIZED COMPOSITIONS OF PROTEINS HAVING A FREE THIOL MOIETY
#2211Nerve growth factor composition and powder injection
#2212VIABLE LYOPHILIZED COMPOSITIONS DERIVED FROM HUMAN TISSUES AND METHODS OF MAKING THE SAME
#2213Method for Preparing Lyophilized Organic Solvent-Free Cyclophosphamide
#2214Resuscitation composition and methods of making and using
#2215Room temperature stable lyophilized protein
#2216Immunogenic compositions comprising conjugated capsular saccharide antigens and uses thereof
#2217Method of preparing a faecal microbiota sample
#2218Compositions and Methods for Treating Irritable Bowel Syndrome and Related Disorders
#2219Method for the Prophylaxis or Treatment of Systemic Lupus Erythematosus and/or Lupus Nephritis
#2220SCALABLE MICROPARTICULATE FORMULATIONS CONTAINING POLYMORPHIC NIMODIPINE FORM 2 PREPARED BY A SOLVENT EVAPORATION PROCESS
#2221Formulations for enteric delivery of therapeutic agents
#2222Thermostable Vaccine Compositions and Methods of Preparing Same
#2223Liquid protein formulations containing 4-(3-butyl-1-imidazolio)-1-butane sulfonate (BIM)
#2224Stabilised Solid Compositions of Factor VII Polypeptides
#2225Therapeutic fusion protein comprising an alpha-n-acetylglucosaminidase and a lysosomal targeting moiety
#2226Anti-obesity composition comprising pine needle juice powder as effective component
#2227Polyomavirus neutralizing antibodies
#2228Pharmaceutical preparation of camptothecin-containing polymer derivative
#2229TIGECYCLINE COMPOSITION FOR INJECTION
#2230Microbiota restoration therapy (MRT) compositions and methods of manufacture
#2231Compositions comprising bacterial strains
#2232PROCESS OF MAKING AND USING PHARMACEUTICAL FORMULATIONS OF ANTINEOPLASTIC AGENTS
#2233Quick dissolving diphenhydramine oral dosage form
#2234Biodegradable polymeric particles encapsulating an active agent, pharmaceutical compositions and uses thereof
#2235Energy recovery in a freeze-drying system
#2236STABLE INTRAVENOUS FORMULATION
#2237Non-protein clostridial toxin compositions
#2238Oncolytic herpes simplex virus infected cells
#2239Probiotic and prebiotic compositions, and methods of use thereof for treatment and prevention of graft versus host disease
#2240Technology for preparation of macromolecular microspheres
#2241Methods and compositions for CNS delivery of arylsulfatase A
#2242Method for the production of a formulation of a hypericin salt
#2243Formulation for photodynamic therapy
#2244Methods and compositions for stabilizing dried biological materials
#2245Compositions comprising bacterial strains
#2246THERAPEUTIC NANOPARTICLES AND METHODS THEREOF
#2247Pharmaceutical formulation containing gelling agent
#2248Crystalline forms of a biphenyl compound
#2249POLYPEPTIDE THERAPEUTICS AND USES THEREOF
#2250Cyclosporine formulations for use in the prevention or treatment of pulmonary chronic graft rejection
#2251Pharmaceutical Composition of Killed Cells with Substantially Retained Immunogenicity
#2252CVS transplantation for treatment of bacterial vaginosis
#2253STABILIZED STATIN FORMULATIONS
#2254Pharmaceutical compositions
#2255Toxoid, Compositions and Related Methods
#2256Microbiota restoration therapy (MRT), compositions and methods of manufacture
#2257Angiogenic Factors
#2258Stable antibacterial composition
#2259Peptide/particle delivery systems
#2260Technology for the Preparation of Microparticles
#2261WATER-SOLUBLE PHARMACEUTICAL COMPOSITION COMPRISING AT LEAST ONE THERAPEUTICALLY ACTIVE SUBSTANCE AND AT LEAST ONE SUBSTANCE CAPABLE OF FORMING MICELLES
#2262Method and device for freeze-drying drug liposomes powder assisted by variable-frequency alternating-current electric field
#2263PROBIOTIC COMPOSITIONS CONTAINING CLOSTRIDIALES FOR INHIBITING INFLAMMATION
#2264DRUG COMPLEXES COMPRISING ALPHA-FETOPROTEIN
#2265METHODS AND COMPOSITIONS OF SMALL MOLECULE MODULATORS OF HEPATOCYTE GROWTH FACTOR (SCATTER FACTOR) ACTIVITY
#2266WOUND HEALING
#2267Cleavable Lipids
#2268Cyclodextrin Compositions Encapsulating a Selective ATP Inhibitor and Uses Thereof
#2269Silybin injection and preparation method therefor
#2270Polymer nanoparticle freeze-dried product, and preparation method therefor
#2271Pharmaceutical compositions containing toxoids A and B
#2272COMPOSITIONS AND METHODS FOR C. DIFFICILE TREATMENT
#2273METHODS OF FORMING AMNIOTIC FLUID-DERIVED PREPARATIONS
#2274Parenteral and topical compositions for pain
#2275Lyophilized mesna compositions
#2276Compositions comprising bacterial strains
#2277Human tissue derived compositions and uses thereof
#2278FORMULATIONS OF BRINCIDOFOVIR
#2279Dihydropyrazoles
#2280Methods of treating arthritis
#2281Allergen dosage form
#2282Formulations of a PI3K/mTor-inhibitor for intravenous administration
#2283Method of manufacturing VEGF antagonist fusion proteins
#2284Pharmaceutical composition comprising plasminogen and uses thereof
#2285PROCESSES FOR PRODUCING STABLE EXOSOME FORMULATIONS
#2286Sunitinib formulations and methods for use thereof in treatment of glaucoma
#2287Analysis compensation including segmented signals converted into signal processing parameters for describing a portion of total error
#2288Stabilizing composition for biological materials
#2289Compositions comprising bacterial strains
#2290Application of derivative of clostridium ghonii
#2291LYOPHILIZED INJECTABLE COMPOSITIONS OF DAPTOMYCIN
#2292Tau protein production accelerator, and therapeutic or preventive agent and therapeutic or preventive food composition for diseases caused by tau protein deficiency
#2293Lyophilized platelet lysates
#2294Lyophilized platelet lysates
#2295Physiologically balanced injectable formulations of fosnetupitant
#2296CONTROLLED RELEASE STERILE INJECTABLE ARIPIPRAZOLE FORMULATON AND METHOD
#2297Treatment of a hematologic malignancy with 2-(4-chlorophenyl)-N-((2-(2,6-dioxopiperidin-3-yl)-1-oxoisoindolin-5-yl)methyl)-2,2-difluoroacetamide
#2298Pharmaceutical composition comprising botulinum, a non ionic surfactant, sodium chloride and sucrose
#2299A Rabies Composition Comprising Pika Adjuvant
#2300System and Method for Multiphasic Release of Growth Factors
#2301compositions and methods of use with ruminants
#2302Anthracycline formulations
#2303Bioactive compounds protection method and compositions containing the same
#2304Methods for the Preparation of Liposomes Comprising Drugs
#2305PRODUCTS AND DEVICES FOR CONTROLLING AND STOPPING BLEEDING AND METHODS OF USING
#2306Methods for reducing the viscosity of liquid pharmaceutical formulations comprising therapeutic proteins
#2307Formulations comprising recombinant acid alpha-glucosidase
#2308HGF preparation suitable for treatment of neurological disorders
#2309Lactobacillus and bacillus based direct fed microbial treatment for poultry and method of use
#2310Formulations having anti-inflammatory activity and antimicrobial activity against gram-positive bacteria
#2311Nanoparticles Containing A Taxane And Their Use
#2312NANOPARTICLES LOADED WITH CHEMOTHERAPEUTIC ANTITUMORAL DRUG
#2313Lyophilized composition of a diazabicyclooctane compound and process of producing the same
#2314Protein-Coupled Red Blood Cell Compositions and Methods of Their Use
#2315Method for treatment of metastatic and refractory cancers and tumors with an inducer that overcomes inhibition of T cell proliferation
#2316Composition of bacteroides thetaiotaomicron for immune modulation
#2317Amniotic membrane preparations and purified compositions and therapy for scar reversal and inhibition
#2318Pharmaceutical Composition Comprising an Artemisinin Derivative for Nasal or Pulmonary Delivery
#2319PARENTERAL ESMOLOL FORMULATION
#23203-substituted piperidine-2, 6-diones and non-covalent complexes with albumin
#2321Injectable, Non-Aqueous Suspension with High Concentration of Therapeutic Agent
#2322Lentiviral vector-based Japanese encephalitis immunogenic composition
#2323Manufacture of Degarelix
#2324Compositions comprising bacterial strains
#2325Preparation containing chlorogenic acid crystal form and use thereof
#2326Method for producing porous particle
#2327Peptide conjugated particles
#2328Long-acting growth hormone treatment
#2329FAST DISSOLVING PHARMACEUTICAL COMPOSITION
#2330Method of activating lactic acid bacteria
#2331COMPOSITIONS AND METHODS FOR TREATING VIRAL HEMORRHAGIC FEVER
#2332COMPOSITIONS AND METHODS FOR TREATING HEPATIC FIBROSIS
#2333Pharmaceutical preparation of camptothecin-containing polymer derivative
#2334Method of preparing stable, water soluble probiotic compositions based on millets and similar cereals
#2335Microbiota restoration therapy (MRT), compositions and methods of manufacture
#2336Solid pharmaceutical compositions comprising biopterin derivatives and uses of suchcompositions
#2337Compositions and methods for bile acid particles
#2338Carrier-binding agent compositions and methods of making and using the same
#2339Pharmaceutical composition containing hydroxamic acid derivative or salt thereof
#2340Therapeutic compositions and uses thereof
#2341Use of GABAA receptor reinforcing agent in preparation of sedative and anesthetic medicament
#2342Composition and method for the treatment of menopause
#2343Method for preparing universal plasma
#2344Botulinum toxin and colloidal silver particles
#2345Preparation containing cephalosporin having a catechol moiety
#2346Collagen-based therapeutic delivery systems
#2347WOUND FLUID ELEVATED PROTEASE ENZYME INHIBITION THROUGH CAMELID BLOOD PRODUCTS
#2348Mangiferin-6-O-berberine salt and preparation method and use thereof
#2349LYOPHILIZED COMPOSITIONS CONTAINING A METAP-2 INHIBITOR
#2350Compositions for stabilizing and delivering proteins
#2351Pharmaceutical composition of polyethylene glycol-modified camptothecin derivative and preparation method thereof
#2352Tigecycline compositions and methods of preparation
#2353System and Method for Multiphasic Release of Growth Factors
#2354Compositions for the Restoration of a Fecal Microbiota and Methods for Making and Using Them
#2355Stable pharmaceutical formulations of methylnaltrexone
#2356COMPOSITIONS AND METHODS FOR STABILIZATION OF ACTIVE AGENTS
#2357Peptide conjugated particles
#2358Microbiota restoration therapy (MRT), compositions and methods of manufacture
#2359Injectable neurosteroid formulations containing nanoparticles
#2360PFKFB3 inhibit and methods of use as an anti-cancer therapeutic
#2361Methods of processing fetal support tissues, fetal support tissue powder products, and uses thereof
#2362Spray-Freeze Drying of Polyelectrolyte Nanoparticles Containing the Protein Drug
#2363Factor VIII formulation
#2364Microbiota restoration therapy (MRT) compositions and methods of manufacture
#2365AGENT, PRODUCT AND USE
#2366Lyophilised pharmaceutical formulation and its use
#2367Targeting-enhanced anticancer nanoparticles and preparation methods of same
#2368ORITAVANCIN FORMULATIONS
#2369Treating a bacterial skin infection with a whole, leech saliva extract
#2370Stable formulations of 5,10-methylene-(6R)-tetrahydrofolic acid
#2371Stable IGG4 based binding agent formulations
#2372METHOD OF MANUFACTURING PROTHROMBIN COMPLEX CONCENTRATE FROM FRACTION III AND NON-PROTHROMBIN COMPLEX CONCENTRATE FROM FRACTION IV
#2373ENHANCEMENT OF SKELETAL MUSCLE STEM CELL ENGRAFTMENT BY DUAL DELIVERY OF VEGF AND IGF-1
#2374Methods and compositions of neuregulins for preventing, treating or delaying preserved ejection fraction cardiac failure
#2375Pharmaceutical compositions comprising FGF19 variants
#2376Lactic acid bacterium
#2377BOTULINUM TOXIN COMPOSITIONS
#2378Subcutaneous administration of ADAMTS13
#2379Remote loading of sparingly water-soluble drugs into lipid vesicles
#2380Aqueous Formulations and Methods of Preparation and Use Thereof
#2381Process for preparing ertapenem-containing lyophilized formulation
#2382Microparticle Enabled Delivery Structures, Methods of Preparing and Using Same
#2383MUCOADHESIVE CARRIERS OF PARTICLES, METHOD OF PREPARATION AND USES THEREOF
#2384Liquid feeding device for the generation of droplets
#2385DAPTOMYCIN FORMULATIONS AND USES THEREOF
#2386NOVEL STRAIN OF LACTOBACILLUS RHAMNOSUS AND ITS METABOLITES FOR USE IN INHIBITING XANTHINE OXIDASE AND TREATING GOUT
#2387Methods and therapeutic combinations for treating tumors
#2388Delivery of bioactive, nanoencapsulated antioxidants
#2389Stable Dual Variable Domain Immunoglobulin Protein Formulations
#2390PROTEIN FORMULATIONS
#2391Pharmaceutical composition comprising bispecific antibody constructs
#2392Process for obtaining fluoride-doped citrate-coated amorphous calcium phosphate nanoparticles
#2393NOVEL COMPOSITION OF MATTER FOR DELIVERING LIPID-SOLUBLE MATERIALS, AND A METHOD FOR PRODUCING IT
#2394LIPOPROTEIN LIPASE FOR TREATMENT OF HYPERTRIGLYCERIDEMIC-RELATED CONDITIONS INCLUDING ACUTE PANCREATITIS
#2395STABLE COMPOSITIONS OF PEPTIDE EPOXY KETONES
#2396Spinal disc regenerative composition and method of manufacture and use
#2397Spinal disc regenerative composition and method of manufacture and use
#2398Solid forms of 2-(4-chlorophenyl)-N-((2-(2,6-dioxopiperidin-3-yl)-1-oxoisoindolin-5-yl)methyl)-2,2-difluoroacetamide, and their pharmaceutical compositions and uses
#2399RADIATION-STERILIZED BIODEGRADABLE DRUG DELIVERY COMPOSITIONS
#2400CONJUGATES OF CARBOXY POLYSACCHARIDES WITH FIBROBLAST GROWTH FACTORS AND VARIANTS THEREOF